International dosage differences in fluoxetine clinical trials.

International dosage differences in fluoxetine clinical trials.

OBJECTIVE: International differences are thought to exist in dosages used by clinicians treating mood disorders. This study examined international dosage differences in antidepressant clinical trials, using a database formed and maintained as a component of a Cochrane review of comparative clinical...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Patten, S, Cipriani, A, Brambilla, P, Nosè, M, Barbui, C
Natura:	Journal article
Lingua:	English
Pubblicazione:	2005

Documenti analoghi

Side-effect profile of fluoxetine in comparison with other SSRIs, tricyclic and newer antidepressants: a meta-analysis of clinical trial data.
di: Brambilla, P, et al.
Pubblicazione: (2005)

Are all antidepressants really the same? The case of fluoxetine: a systematic review.
di: Cipriani, A, et al.
Pubblicazione: (2006)

Fluoxetine versus other types of pharmacotherapy for depression.
di: Cipriani, A, et al.
Pubblicazione: (2005)

Fluoxetine versus other types of pharmacotherapy for depression
di: Cipriani, A, et al.
Pubblicazione: (2009)

Fluoxetine and amitriptyline: First-line treatments or reference compounds?
di: Barbui, C, et al.
Pubblicazione: (2004)

Allocation concealment and blinding in clinical trials.
di: Cipriani, A, et al.
Pubblicazione: (2008)

Fluoxetine versus other types of pharmacotherapy for depression
di: Magni, L, et al.
Pubblicazione: (2013)

"Wish bias" in antidepressant drug trials?
di: Barbui, C, et al.
Pubblicazione: (2004)

Efficacy and tolerability of pharmacological treatments for personality disorders: A meta-analysis
di: Nose, M, et al.
Pubblicazione: (2005)

What is a risk ratio?
di: Cipriani, A, et al.
Pubblicazione: (2007)

Efficacy of pharmacotherapy against core traits of borderline personality disorder: meta-analysis of randomized controlled trials.
di: Nosè, M, et al.
Pubblicazione: (2006)

Outcome reporting bias in clinical trials.
di: Esposito, E, et al.
Pubblicazione: (2009)

Why internal and external validity of experimental studies are relevant for clinical practice?
di: Cipriani, A, et al.
Pubblicazione: (2009)

EMA must improve the quality of its clinical trial reports.
di: Barbui, C, et al.
Pubblicazione: (2011)

Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia: a 12-month, randomized, naturalistic trial.
di: Cipriani, A, et al.
Pubblicazione: (2013)

Cluster randomised trials.
di: Barbui, C, et al.
Pubblicazione: (2011)

Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial.
di: Barbui, C, et al.
Pubblicazione: (2011)

What is a factorial trial?
di: Cipriani, A, et al.
Pubblicazione: (2013)

Simple spectrophotometric methods for determination of fluoxetine and clomipramine hydrochlorides in dosage forms and in some post-mortem biological fluids samples
di: Emam A. Ali, et al.
Pubblicazione: (2016-12-01)

Explanatory and pragmatic trials.
di: Barbui, C, et al.
Pubblicazione: (2007)

Assessing risk of bias in randomized controlled trials.
di: Purgato, M, et al.
Pubblicazione: (2010)

Imputing response rates from means and standard deviations in meta-analyses.
di: Furukawa, T, et al.
Pubblicazione: (2005)

Imputing missing standard deviations in meta-analyses can provide accurate results.
di: Furukawa, T, et al.
Pubblicazione: (2006)

An open-label trial of risperidone and fluoxetine in children with autistic disorder
di: Desousa Avinash
Pubblicazione: (2010-01-01)

Randomized trials published in Chinese or Western journals: comparative empirical analysis.
di: Purgato, M, et al.
Pubblicazione: (2012)

Fluoxetine in Tourette Syndrome
di: J Gordon Millichap
Pubblicazione: (1991-07-01)

Fluoxetine and suicidal behaviour. Some clinical and theoretical aspects of a controversy.
di: Power, A, et al.
Pubblicazione: (1992)

Ecofriendly and smart spectrophotometric approaches for synchronized analysis of two antipsychotic drugs, fluoxetine and olanzapine: application to combined tablet dosages with assessment of method greenness
di: Sayed M Derayea, et al.
Pubblicazione: (2025-02-01)

[Randomized trials, systematic reviews, meta-analyses: basic criteria in the world of scientific evidence].
di: Purgato, M, et al.
Pubblicazione: (2012)

Understanding antipsychotic non-classical prescriptions: a quantitative and qualitative approach.
di: Veronese, A, et al.
Pubblicazione: (2008)

Tianeptine, but not fluoxetine, decreases avoidant behavior in a mouse model of early developmental exposure to fluoxetine
di: Elizabeth A. Pekarskaya, et al.
Pubblicazione: (2021-11-01)

Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial
di: Hashemi SN, et al.
Pubblicazione: (2012-01-01)

Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia.
di: Cipriani, A, et al.
Pubblicazione: (2009)

Antidepressant Effect of Asperugo procumbens L. in Comparison with Fluoxetine: a Randomized Double Blind Clinical Trial
di: Mehran Zarghami, et al.
Pubblicazione: (2018-06-01)

Fluoxetine improves minor depressive disorders.
di: Cowen, P
Pubblicazione: (2005)

Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials.
di: Barbui, C, et al.
Pubblicazione: (2008)

Serum sodium changes in fluoxetine users at different age groups.
di: Fereshteh Shakibaei, et al.
Pubblicazione: (2010-09-01)

Serum Sodium Changes in Fluoxetine Users at Different Age Groups
di: Khalil Talaeizadeh, et al.
Pubblicazione: (2010-08-01)

Clinical efficacy and safety of fluoxetine in generalized anxiety disorder in Chinese patients
di: Zou C, et al.
Pubblicazione: (2013-11-01)

The Possible Role of Fluoxetine in Adenomyosis: An Animal Experiment with Clinical Correlations
di: Parama Sengupta, et al.
Pubblicazione: (2013-07-01)